Sign in

CIK 0001649094 · Large accelerated filer

Vaxcyte, Inc.

Sign in to watch
Ticker
PCVX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464233385
Phone
650-837-0111
Business address
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
Former names
SutroVax, Inc.
  1. 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at an average $53.89 ($538,879)
  2. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 18,198 shares at an average $55.63 ($1,012,375)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at an average $57.28 ($572,837)
  6. 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $56.33 ($126,736)
  7. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 24,237 shares at an average $55.22 ($1,338,270)
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale CHIEF EXECUTIVE OFFICER sold 24,461 shares at an average $52.50 ($1,284,205)
  11. 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at $53.00 ($530,000)
  12. 4 Grant or award Director acquired 2,265 shares (grant or award)
  13. 4 Grant or award Director acquired 2,194 shares (grant or award)
  14. 4 Grant or award Director acquired 2,265 shares (grant or award)
  15. 4 Grant or award Director acquired 2,265 shares (grant or award)
  16. 4 Grant or award Director acquired 2,265 shares (grant or award)
  17. 4 Grant or award Director acquired 2,265 shares (grant or award)
  18. 4 Grant or award Director acquired 2,265 shares (grant or award)
  19. 4 Grant or award Director acquired 2,265 shares (grant or award)
  20. 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $49.52 ($111,416)

Page 2 of 22 · 421 filings